Exploring the power of ZT Scan DIA

Feb 7, 2025 | Blogs, Life Science Research, Proteomics, ZenoTOF 7600+ system | 0 comments

Read time: 2 minutes

In a recent presentation, Tim Heymann from Mann Lab at the Max Planck Institute of Biochemistry shared his first impressions of ZT Scan DIA, the novel data-independent acquisition strategy from SCIEX, highlighting its innovative approach and significant benefits for proteomics research. Let’s dive into the key points from his insightful talk.

Understanding ZT Scan DIA

ZT Scan DIA offers a more efficient scan mode than regular SWATH DIA. The major difference lies in the continuous scan with overlapping windows, which eliminates overhead time and provides an additional Q1 scanning dimension. This results in a more efficient and detailed analysis, allowing researchers to distinguish between different precursors even if they appear to coelute.

Benchmarking ZT Scan DIA

Tim’s initial benchmarks focused on three performance assessments with a K562 digest: bulk-level analysis, lower sample inputs and short gradients. Using the Evosep One system coupled to the ZenoTOF 7600+ system, he tested various setups for higher coverage and throughput. The results were promising, showing a noticeable increase in identifications (IDs) at both the precursor and protein group levels.

Performance at different loads and gradients

ZT Scan DIA significantly boosted performance, especially at lower sample loads and shorter LC gradients. For instance, at 50 nanograms, there was a 50% gain in protein IDs, and at 500 SPD, the increase in quantifiable precursors was almost 100%. This robust performance across different settings highlights the versatility and efficiency of ZT Scan DIA.

Insights into phosphoproteomics

When analyzing phosphopeptides, ZT Scan DIA showed more than 10% gains in phosphosite detections, particularly in the lower abundant range. Although the overlap with Zeno SWATH DIA was lower, this was expected due to the enrichment process in phosphoproteomics. The enhanced selectivity of ZT Scan DIA provides more confidence in identifying phosphosites.

Leveraging AlphaDIA and Transfer Learning for data processing

Tim also discussed using AlphaDIA and Transfer Learning to maximize data analysis. By adapting models to different patterns and setups, AlphaDIA can significantly improve identification rates. Although current limitations prevent full access to the Q1 scanning dimension, ongoing developments promise even better performance in the future.

Conclusion

Overall, ZT Scan DIA represents a substantial advancement in proteomics research. It offers a performance boost that becomes more pronounced at lower loads and faster gradients. With its innovative approach and robust results, ZT Scan DIA is poised to impact the field significantly.

Watch Tim’s presentation here

Related links:

Technical overview: Continuing the data-independent acquisition (r)evolution: Introducing ZT Scan DIA for quantitative proteomics

Nature Portfolio article: Fast, sensitive or accurate? Proteomics researchers can now have all three.

PFAS testing: 2024 in review and what to expect for 2025

For as long as PFAS persist in the environment, there is no doubt they will persist in our conversations as environmental scientists. Globally, PFAS contamination has been detected in water supplies, soil and even in the blood of people and wildlife. Different countries are at various stages of addressing PFAS contamination and many governments have set regulatory limits and are working on assessing the extent of contamination, cleaning up affected sites and researching safer alternatives.

Inside the box: Acoustic ejection mass spectrometry for drug discovery

On average, it takes 10-15 years and 1-2 billion dollars to approve a new pharmaceutical for clinical use. Since approximately 90% of new drug candidates fail in clinical development, the ability to make early, informed and accurate decisions on the safety and efficacy of new hits and leads is key to increasing the chances of success.

Unveiling the power of ZT Scan DIA: Insights from Ludwig Sinn’s presentation at World HUPO Congress 2024

In a recent presentation at the World HUPO Congress 2024, Ludwig Sinn from the Ralser lab shared exciting advancements in proteomics research, focusing on the innovative ZT Scan DIA acquisition modes developed in collaboration with SCIEX. Let us explore the key highlights and benefits of this innovative technology.

Posted by

I developed a foundational understanding of biochemistry during my undergraduate studies before gaining a masters in molecular and cellular biophysics, and finally obtaining my Ph.D conducting in-depth proteomics research in peanut allergy. I started at SCIEX in the applications support team, later being promoted to the application lead for life science research in EMEAI. I am currently leading global strategic marketing efforts, contributing to the advancement of small molecule OMICS. This role is pivotal in bridging the gap between scientific innovation and market demand, ensuring that products and workflows not only meet the needs of the market but also stand out in a competitive landscape.

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial